TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15914936

Group type: EXPERIMENTAL
Intervention: β-blockers, angiotensin-converting enzyme inhibitors, aldosterone antagonists, and statins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillators (ICD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ICD treatment
Number of subjects: 0
Study: 14664728

Group type: EXPERIMENTAL
Intervention: Selenium and Vitamin E
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 10836327

Group type: EXPERIMENTAL
Intervention: 25 microg salmeterol
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 50 microg salmeterol
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 100 microg salmeterol
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 7888013

Group type: EXPERIMENTAL
Intervention: RU 486 (600 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cortisol (2 micrograms/kg.min for 5 h)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: RU 486 before normal saline infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cortisol infusion
Number of subjects: 8
Study: 1943180

Group type: EXPERIMENTAL
Intervention: Herbomineral formulation (Articulin‐F)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 7032568

Group type: EXPERIMENTAL
Intervention: Annual screening by mammography and/or clinical examination
Number of subjects: 120000

Group type: EXPERIMENTAL
Intervention: Education sessions in breast self-examination
Number of subjects: 120000

Group type: COMPARATOR
Intervention: No additional services beyond conventional diagnostic facilities
Number of subjects: 120000
Study: 31183663

Group type: EXPERIMENTAL
Intervention: CRISPR/Cas9 system with guide RNA 1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CRISPR/Cas9 system with guide RNA 2
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CRISPR/Cas9 system
Number of subjects: 100
Study: 29065426

Group type: EXPERIMENTAL
Intervention: FOLFOX-4 or XELOX adjuvant chemotherapy
Number of subjects: 508
Study: 27045714

Group type: EXPERIMENTAL
Intervention: CCRT (24 one‐hour sessions over 2 months)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Limited CCRT (same games rotated randomly from simple to moderate levels of training)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: CCRT (both arms)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Passive control group (no training)
Number of subjects: 159
Study: 24577971

Group type: EXPERIMENTAL
Intervention: Nuevo Amanecer program (peer-delivered cognitive-behavioral stress management intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nuevo Amanecer program
Number of subjects: 0
Study: 22395893

Group type: EXPERIMENTAL
Intervention: Subthreshold laser treatment (STLT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Threshold laser treatment (TLT)
Number of subjects: 25
Study: 21118925

Group type: EXPERIMENTAL
Intervention: artesunate-mefloquine (AM)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: dihydroartemisinin-piperaquine (DP)
Number of subjects: 300
Study: 17558725

Group type: EXPERIMENTAL
Intervention: Cereal Substitution plus Nutrient Bar (CB)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Cereal and Waffle Substitution plus Nutrient Bar (CWB)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Cereal Substitution, no Nutrient Bar (CR)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (CN)
Number of subjects: 164
Study: 16351338

Group type: EXPERIMENTAL
Intervention: Moving to Opportunity Program (voucher to move to low-poverty neighborhoods)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Low-poverty neighborhoods
Number of subjects: 425

Group type: COMPARATOR
Intervention: High-poverty neighborhoods
Number of subjects: 425
Study: 12150481

Group type: EXPERIMENTAL
Intervention: Streptomycin 30 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Streptomycin 15 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Streptomycin 7.5 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paromomycin 7.5 mg/kg
Number of subjects: 0
Study: 10467532

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl-rutosides applied every 3 or 4 hours during the flight
Number of subjects: 51
Study: 8778155

Group type: EXPERIMENTAL
Intervention: Octreotide (300 micrograms/d)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1330386

Group type: EXPERIMENTAL
Intervention: Lisinopril 10-20 mg once daily
Number of subjects: 219

Group type: COMPARATOR
Intervention: Felodipine 5-10 mg once daily
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 219

Group type: COMPARATOR
Intervention: Felodipine
Number of subjects: 219
Study: 2869615

Group type: EXPERIMENTAL
Intervention: Propranolol in a daily dose of 180 to 240 mg
Number of subjects: 0
Study: 29148630

Group type: EXPERIMENTAL
Intervention: BP+LP with rest
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: BP+LP no rest
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: LP+BP with rest
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: LP+BP no rest
Number of subjects: 28
Study: 29023875

Group type: EXPERIMENTAL
Intervention: Group A (technical endpoint)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Group B (pursuing AF termination)
Number of subjects: 400
Study: 29071875

Group type: EXPERIMENTAL
Intervention: Oral-appliance plus tadalafil (10 mg daily for 3 months)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral-appliance
Number of subjects: 90

Group type: COMPARATOR
Intervention: Tadalafil (10 mg daily for 3 months)
Number of subjects: 90
Study: 25772743

Group type: EXPERIMENTAL
Intervention: Next.Step e-therapeutic platform accessed during 24 weeks in addition to standard treatment program
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard treatment protocol
Number of subjects: 94
Study: 22715808

Group type: EXPERIMENTAL
Intervention: 400 mg of DHA
Number of subjects: 285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285
Study: 21521341

Group type: EXPERIMENTAL
Intervention: Oral DHEA 50 mg/day
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 18773374

Group type: EXPERIMENTAL
Intervention: Regional Psychiatry Budget (RPB) model
Number of subjects: 502

Group type: COMPARATOR
Intervention: Fee-for-service principle (Control Region)
Number of subjects: 502
Study: 16581113

Group type: EXPERIMENTAL
Intervention: Intralesional interferon-alpha 2b combined with oral vitamin E
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intralesional interferon-alpha 2b alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral vitamin E alone
Number of subjects: 30
Study: 12701068

Group type: EXPERIMENTAL
Intervention: Mixed meals containing 15,000 retinol equivalents (RE) of vitamin A (as retinyl palmitate) with 40 g of fat (butter)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mixed meals containing 15,000 retinol equivalents (RE) of vitamin A (as retinyl palmitate) with 40 g of fat (olive oil)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mixed meals containing 15,000 retinol equivalents (RE) of vitamin A (as retinyl palmitate) with 40 g of fat (sunflower oil)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mixed meals containing 15,000 retinol equivalents (RE) of vitamin A (as retinyl palmitate) with no fat (fat-free meal)
Number of subjects: 10
Study: 10928254

Group type: EXPERIMENTAL
Intervention: 2% lignocaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 30
Study: 9105948

Group type: EXPERIMENTAL
Intervention: High task load visual task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low task load visual task
Number of subjects: 0
Study: 7963281

Group type: EXPERIMENTAL
Intervention: Home-based program with music listening stress reduction techniques at weekly home visits by a music therapist
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Self-administered program with music listening stress reduction techniques and moderate therapist intervention (weekly telephone call)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 30
Study: 3297718

Group type: EXPERIMENTAL
Intervention: Ambroxol (120 mg/day) for 40 days after chemotherapy course
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29077226

Group type: EXPERIMENTAL
Intervention: Shark fin trade assessment using genetic identification of fin trimmings
Number of subjects: 4800

Group type: EXPERIMENTAL
Intervention: Bayesian model for species composition
Number of subjects: 4800

Group type: EXPERIMENTAL
Intervention: Assessment of management measures
Number of subjects: 4800
Study: 26833744

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 4372
Study: 25556490

Group type: EXPERIMENTAL
Intervention: Fluvoxamine combined with oxycodone prolonged-release tablets
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oxycodone prolonged-release tablets alone (Control)
Number of subjects: 120
Study: 22250667

Group type: EXPERIMENTAL
Intervention: Warning message for potential fakers in Study 1
Number of subjects: 543

Group type: COMPARATOR
Intervention: Nonwarning (control) message for nonfakers in Study 1
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Warning message in Study 2
Number of subjects: 543

Group type: COMPARATOR
Intervention: Control message in Study 2
Number of subjects: 543
Study: 19765784

Group type: EXPERIMENTAL
Intervention: Simulated altitude (ALT, 4300 m)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ambient conditions (AMB, 362 m)
Number of subjects: 8
Study: 17884832

Group type: EXPERIMENTAL
Intervention: Fixed-dose paediatric granule co-formulation (10-20 kg body weight)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Free-dose co-blister tablet formulation of artesunate-mefloquine (>20-40 kg body weight)
Number of subjects: 24
Study: 15722369

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 12148181

Group type: EXPERIMENTAL
Intervention: Pollinex
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Allergovit
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Pollinex or Allergovit
Number of subjects: 27
Study: 9296767

Group type: EXPERIMENTAL
Intervention: Cyfra 21-1 levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyfra 21-1 concentration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High Cyfra 21 levels
Number of subjects: 0
Study: 3353893

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (3.2 g eicosapentaenoic acid and 2.2 g docosahexaenoic acid daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (olive oil capsules)
Number of subjects: 20
Study: 31227535

Group type: EXPERIMENTAL
Intervention: Daily oral probiotic combination of Lactobacillus rhamnosus, GG (LGG) and Bifidobacterium animalis subsp. lactis, BB‐12 (BB‐12)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 28463747

Group type: EXPERIMENTAL
Intervention: CBT-SP (Cognitive Behaviour Therapy with Support Person)
Number of subjects: 201

Group type: COMPARATOR
Intervention: CBT-A (Cognitive Behaviour Therapy Alone)
Number of subjects: 201
Study: 24602689

Group type: EXPERIMENTAL
Intervention: Moderate exercise group (150 additional minutes of exercise per week)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Extensive exercise group (300 additional minutes of exercise per week)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 129
Study: 23015541

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (65 mg)
Number of subjects: 128

Group type: COMPARATOR
Intervention: De-caffeinated coffee
Number of subjects: 128
Study: 21464363

Group type: EXPERIMENTAL
Intervention: High alcohol dose (0.8 g/kg)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Low alcohol dose (0.4 g/kg)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Heavy drinkers
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Binge drinking frequency during follow‐up
Number of subjects: 190
Study: 19394989

Group type: EXPERIMENTAL
Intervention: Malaria education
Number of subjects: 213
Study: 17091055

Group type: EXPERIMENTAL
Intervention: Coca tea consumption
Number of subjects: 5
Study: 14969023

Group type: EXPERIMENTAL
Intervention: Profore (four-layer bandage system)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Unna's Boot
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Profore
Number of subjects: 68
Study: 11817382

Group type: EXPERIMENTAL
Intervention: Participation in a therapeutic trial
Number of subjects: 43
Study: 9457454

Group type: EXPERIMENTAL
Intervention: Topical tetracaine 1%
Number of subjects: 38

Group type: COMPARATOR
Intervention: Topical bupivacaine 0.75%
Number of subjects: 38
Study: 7649759

Group type: EXPERIMENTAL
Intervention: Supportive community intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (adolescents who did not experience peer suicide)
Number of subjects: 0
Study: 2514474

Group type: EXPERIMENTAL
Intervention: Oxamniquine 20, 30 or 40 mg/kg
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Praziquantel 20, 30 or 40 mg/kg
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Praziquantel 30 or 40 mg/kg
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Oxamniquine 40 mg/kg
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Higher dosages of both drugs
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Cured adults in Bulamata
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Adults in Bulinga and Maramvya
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Population chemotherapy
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Lower treatment schedules
Number of subjects: 1320
Study: 1055315

Group type: EXPERIMENTAL
Intervention: Clonidine alone or in conjunction with diuretics and other hypertensive drugs
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 50
Study: 31314549

Group type: EXPERIMENTAL
Intervention: More intensive surveillance strategies
Number of subjects: 35200

Group type: COMPARATOR
Intervention: Less intensive surveillance strategies
Number of subjects: 35200
Study: 28682969

Group type: EXPERIMENTAL
Intervention: Early colonoscopy (<30 days from referral)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Standard-schedule colonoscopy
Number of subjects: 257
Study: 24663814

Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum (6 g/day for 5 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sorbitol chewing gum (control group)
Number of subjects: 73
Study: 23158806

Group type: EXPERIMENTAL
Intervention: AG200-15 Agile Patch (AP) under normal conditions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: AG200-15 Agile Patch (AP) under cool water conditions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: AG200-15 Agile Patch (AP) under all conditions
Number of subjects: 24
Study: 22285289

Group type: COMPARATOR
Intervention: Placebo effects
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 12

Group type: COMPARATOR
Intervention: Psychological mechanisms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Holistic models of healing
Number of subjects: 12

Group type: COMPARATOR
Intervention: Negative views of placebos
Number of subjects: 12
Study: 19616494

Group type: EXPERIMENTAL
Intervention: BCG vaccination at 10 weeks of age
Number of subjects: 46

Group type: COMPARATOR
Intervention: BCG vaccination at birth
Number of subjects: 46
Study: 17900512

Group type: EXPERIMENTAL
Intervention: Cationic propyl gallate (CPG)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Adenosine diphosphate (ADP)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both CPG and ADP
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 116
Study: 14991243

Group type: EXPERIMENTAL
Intervention: [(18)F]fluorothymidine (FLT) PET
Number of subjects: 12
Study: 11254838

Group type: EXPERIMENTAL
Intervention: Peripheral venous pressure (PVP) during surgery
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Peripheral venous pressure (PVP) in the postanesthesia care unit
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fluid challenge (2-L) in intraoperative patients
Number of subjects: 150
Study: 9479686

Group type: EXPERIMENTAL
Intervention: Civilian version of the Mississippi Scale for Combat‐Related PTSD (CM‐PTSD)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Trauma Symptom Checklist‐40 (TSC‐40)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Response to Childhood Incest Questionnaire (RCIQ)
Number of subjects: 52
Study: 7913934

Group type: EXPERIMENTAL
Intervention: RAI alone
Number of subjects: 114

Group type: COMPARATOR
Intervention: Adjunctive antithyroid drugs (MMI and L-T4)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Both groups (RAI and adjunctive antithyroid drugs)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: MMI
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Patients with hypothyroidism and elevated TSH
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Patients with no ophthalmopathy at presentation
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Patients who developed or had exacerbation of GO
Number of subjects: 114
Study: 2847600

Group type: EXPERIMENTAL
Intervention: 1 mg nedocromil sodium
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 4 mg nedocromil sodium
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 8 mg nedocromil sodium
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30471715

Group type: EXPERIMENTAL
Intervention: rhIGF-1/rhIGFBP-3 (250 µg/kg/24 hours, continuous intravenous infusion from <24 hours of birth to postmenstrual age 296/7 weeks)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard neonatal care
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: rhIGF-1/rhIGFBP-3
Number of subjects: 121

Group type: COMPARATOR
Intervention: rhIGF-1/rhIGFBP-3 and Standard neonatal care
Number of subjects: 121
Study: 27505045

Group type: EXPERIMENTAL
Intervention: Early flap coverage (≤3 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Late flap coverage (>3 weeks)
Number of subjects: 55
Study: 25196399

Group type: EXPERIMENTAL
Intervention: Home-based dispensing of hormonal contraceptives by nurses
Number of subjects: 24
Study: 23744766

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 9
Study: 22142523

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Greater occipital nerve block with steroid
Number of subjects: 30
Study: 19737849

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor prescribed to be taken as needed for relief of epigastric pain
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16490093

Group type: EXPERIMENTAL
Intervention: Caudal morphine (30 microg.kg(‐1) in 1 ml.kg(‐1) saline)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Caudal bupivacaine (0.25%)
Number of subjects: 28
Study: 14642016

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 11345025

Group type: EXPERIMENTAL
Intervention: Ukrain (10 mg every second day, repeated 10 times) and vitamin C (5.4 g every second day, repeated 10 times)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (vitamin C (5.4 g every second day, repeated 10 times) and normal saline (10 ml))
Number of subjects: 42
Study: 9192511

Group type: EXPERIMENTAL
Intervention: Intermittent cyclical etidronate (400 mg/day for 14 days) followed by cyclical calcitriol therapy (0.25 microg twice daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.25 microg twice daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.25 microg/day) in combination with 100 IU intranasal salmon calcitonin every other day
Number of subjects: 30
Study: 1492900

Group type: EXPERIMENTAL
Intervention: Portable infra-red CO2 detector
Number of subjects: 50
Study: 3515920

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (200 to 300 mg total daily dosage, four times daily)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 31860408

Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 365

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 365
Study: 29962548

Group type: EXPERIMENTAL
Intervention: Intervention arm (educational sessions with male partners)
Number of subjects: 1144

Group type: COMPARATOR
Intervention: Control arm (routine care only)
Number of subjects: 1144
Study: 27261984

Group type: EXPERIMENTAL
Intervention: Yoga program for 12 weeks
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise-training program for 12 weeks
Number of subjects: 335

Group type: COMPARATOR
Intervention: Usual activity group
Number of subjects: 335
Study: 24218048

Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22682100

Group type: EXPERIMENTAL
Intervention: IVR self-monitoring system
Number of subjects: 87
Study: 20140408

Group type: EXPERIMENTAL
Intervention: Rehabilitation (18 sessions including manual mobilization, taping and exercises, n = 29)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Rehabilitation (n = 15 compliant patients)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Rehabilitation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (wait-list, n = 19)
Number of subjects: 48
Study: 17239139

Group type: EXPERIMENTAL
Intervention: True bipolar configuration (Medtronic Sprint Quattro)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: True bipolar configuration (St. Jude Riata)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Integrated bipolar configuration (Medtronic Sprint Quattro)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Integrated bipolar configuration (St. Jude Riata)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: True bipolar configuration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Integrated bipolar configuration
Number of subjects: 40